Alaunos Therapeutics, Inc.
- TCRT
- NASDAQ
- Biotechnology
- Oncology Biotech
- TCR-T Cell Therapy
$3.12
Today +18.44%Quote Oct 19, 2026, 07:39 PM UTC
+64.37%over the last month
Max drawdown −53.6%From 1-month high −13.2%3 months +29.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Alaunos Therapeutics
Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
1
Market value
$7.9M
Quote Oct 19
Floor
$3.04
2.4% below price
Resistance
$3.11
Price is above this level
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TCRTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free